Image
18.11.2021
Dapagliflozin (Forxiga) is no longer to be used for type 1 diabetes
AstraZeneca has announced that the medication Dapagliflozin (Forxiga) will no longer be licensed for use ...
In our October research highlights, we look at a world-first stem cell transplant which helped a person with type 1 diabetes produce insulin, and how electrical impulses could regenerate cells in people with type 2 diabetes.
Read more